Company for sale
- Sales: <5 million EUR
- Location: Western Europe, exact location will be disclosed to seriously interested parties
- Reason for sale: The owners decided to step out of the business they built, therefore they are willing to talk with strong players in the industry
- #CFIE PHS119
Overview of the high-value generic and pharmaceutical products for women’s health for sale
The company develops high-value generics and pharmaceutical products for women’s health, having been founded in the early 1990s as a result of particular research developments. Since the mid-2000s, the company has focused on the development of generic prostaglandins.
The company is looking for a major investor for new products with a share of company capital as part of the deal and/or a sale of the whole company including the products. The company is fully licensed and an active distribution licensee and is fully GDP compliant.
Profile (strategy) of the high-value generic and pharmaceutical products for women’s health for sale
The company’s strategy is centered on the development of prostaglandins as specialty generic drugs, as well as prostaglandins for novel indications and other niche products. It develops high-value prostaglandin-based drugs, specializing in sophisticated products with high market entry barriers, unlikely to be attracted by developers of mass products.
Contact us to get details about this High-value generics and pharmaceutical products for women’s health for sale
Activities and products of the high-value generic and pharmaceutical products for women’s health for sale
The company manufactures medicine for pulmonary arterial hypertension, controlled ovarian hyperstimulation for ART, platelet development, prostate cancer, and the prevention of premature ovulation. The company has an API unit focused on providing the best quality APIs to industrial clients.
Highlights of the high-value generic and pharmaceutical product developer for women’s health for sale
- High-quality personnel with experience in pharma R&D
- High barriers to entry with differentiated pharma products
- Exceptional location in Western Europe, close to main suppliers, consumers, and European infrastructure
- 20+ years of experience in its niche
More information on this high-value generic and pharmaceutical product for women’s health for sale
Please get in touch if you are interested in learning more about this high-value generic and pharmaceutical product for women’s health for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.
Subscribe as an interested buyer for this CRO company for sale
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.
English (UK) 
Nederlands 
Français 
Deutsch 
Español 
Italiano